2025-07-11 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the provided data, presented in a report format with an emphasis on key numbers and concise interpretations.

## Colgate-Palmolive (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive Co. is a global consumer products company focused on the production, distribution, and provision of household, health care, personal care, and pet nutrition products.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 18.43%
*   **VOO Cumulative Return:** 96.17%
*   **Absolute Divergence:** -75.4%
*   **Relative Divergence:** 0.0 (Indicates the current divergence is at the lowest end of its historical range.)

**Analysis:** Colgate-Palmolive has significantly underperformed the S&P 500 over the period analyzed. The relative divergence indicates that this underperformance is at the extreme lower end of its historical range, suggesting a potential opportunity for mean reversion, or a continuation of the trend.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha    | Beta   | Cap(B) |
| ---------- | ------ | ----- | -------- | ------ | ------ |
| 2015-2017  | 13.0%  | 4.5%  | -16.0%   | 0.0    | 61.1   |
| 2016-2018  | -11.0% | 65.2% | -29.0%   | 0.1    | 48.2   |
| 2017-2019  | 7.0%   | 65.2% | -22.0%   | 0.1    | 55.8   |
| 2018-2020  | 18.0%  | 65.2% | -2.0%    | 0.6    | 69.3   |
| 2019-2021  | 30.0%  | 58.6% | -19.0%   | 0.7    | 69.2   |
| 2020-2022  | 7.0%   | 69.0% | 5.0%     | 0.7    | 63.9   |
| 2021-2023  | 6.0%   | 69.0% | -12.0%   | 0.8    | 64.6   |
| 2022-2024  | 13.0%  | 69.0% | -12.0%   | 0.8    | 73.7   |
| 2023-2025  | 5.0%   | 70.6% | -43.0%   | 0.3    | 73.4   |

**Analysis:**

*   **Alpha:** Colgate-Palmolive has consistently exhibited negative alpha values in the majority of periods, indicating underperformance compared to its benchmark, except for the 2020-2022 period. The most recent period (2023-2025) shows a significant negative alpha of -43.0%.
*   **Beta:** The beta values are generally low, suggesting that Colgate-Palmolive's stock price is less sensitive to overall market movements. However, beta has been increasing over time, particularly from 2018 onwards, indicating that the stock is becoming more correlated with the market.
*   **CAGR:** The compound annual growth rate (CAGR) has varied, with periods of strong growth and periods of decline. The most recent period (2023-2025) shows a modest CAGR of 5.0%.
*   **MDD:** The maximum drawdown (MDD) values are relatively high, especially from 2016-2018 onwards, indicating significant potential losses during market downturns. The most recent period (2023-2025) shows the highest MDD of 70.6%.
*   **Market Capitalization (Cap):** The market capitalization has generally increased over the years, indicating that the company has grown in size.

### 2. Recent Stock Price Movement

*   **Current Price:** 90.62
*   **Previous Close:** 91.58
*   **Change:** -1.05
*   **5-Day Moving Average:** 91.95
*   **20-Day Moving Average:** 90.32
*   **60-Day Moving Average:** 91.26

**Analysis:** The stock price has recently decreased, closing lower than its previous day's price. The price is currently below the 5-day and 60-day moving averages but above the 20-day moving average. This suggests a short-term downward trend, but the mixed signals from the moving averages warrant further observation.  The negative change from the previous close does indicate a slight downward pressure.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI:** 61.37 (Approaching overbought territory)
*   **PPO:** 0.28 (Positive, indicating a possible upward trend)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Short-term decline)
*   **Expected Return (%):** -3590.3% (Significantly negative, indicating potential underperformance compared to the S&P 500 over a long-term investment horizon)

**Analysis:** The Market Risk Indicator suggests a low-risk environment for the stock.  The RSI is approaching overbought levels, which could indicate a potential pullback. The PPO being positive might signal some upward momentum. However, the drastically negative expected return is a major concern. This, coupled with the recent short-term decline in relative divergence, paints a mixed picture.  The hybrid signal is slightly cautious.

### 4. Recent News & Significant Events

*   **[2025-07-10]:**  Colgate-Palmolive Co (CL) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-07]:** Analysts are discussing Colgate-Palmolive Co's (CL) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-07-11]:** Colgate-Palmolive Co (CL)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-08]:** Market experts highlight both risks and opportunities for Colgate-Palmolive Co (CL), advising investors to monitor recent news and company announcements.

**Analysis:** The news suggests recent activity and potential volatility affecting the stock. Monitoring these news events, earnings reports, and company announcements is crucial for informed decision-making.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출      |
| ------------ | ---- | --------- |
| 2025-04-25   | 0.85 | 4.91 B$   |
| 2024-10-25   | 0.9  | 5.03 B$   |
| 2024-07-26   | 0.89 | 5.06 B$   |
| 2024-04-26   | 0.83 | 5.07 B$   |
| 2025-04-25   | 0.83 | 5.07 B$   |

**Analysis:** The EPS (Earnings Per Share) has fluctuated slightly, with a recent dip. Revenue shows a slight decrease over the past few quarters. Consistent revenue and EPS are expected for stable, mature companies, but decreases can signal problems or changing market conditions.

### 6. Financial Information: Revenue and Profitability

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-03-31   | $4.91B   | 60.82%        |
| 2024-12-31   | $4.95B   | 60.30%        |
| 2024-09-30   | $5.03B   | 61.08%        |
| 2024-06-30   | $5.06B   | 60.62%        |
| 2024-03-31   | $5.07B   | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
| ------------ | --------- | --------- |
| 2025-03-31   | $0.36B   | 190.08%   |
| 2024-12-31   | $0.21B   | 348.58%   |
| 2024-09-30   | $0.43B   | 169.43%   |
| 2024-06-30   | $0.12B   | 594.31%   |
| 2024-03-31   | $0.23B   | 296.96%   |

**Analysis:** The company maintains a very high profit margin, indicating strong pricing power and efficient cost management. However, revenue has slightly decreased over the recent quarters. The Return on Equity (ROE) is exceptionally high, which could be due to lower equity values. It is important to understand the context of these high ROE figures, as they might be inflated by specific accounting practices or one-time events.

### 7. Overall Analysis

Colgate-Palmolive (CL) presents a mixed investment picture. While the company demonstrates strong profit margins and a low-risk profile according to the MRI, it has significantly underperformed the S&P 500.

**Key Concerns:**

*   **Significant Underperformance:**  The stark difference in cumulative returns compared to the S&P 500 is a major red flag.
*   **Negative Expected Return:** The extremely negative projected return raises serious questions about the stock's long-term potential.
*   **Revenue Decline:** The slight but consistent decrease in revenue warrants further investigation to determine its underlying cause.

**Potential Positives:**

*   **High Profit Margins:**  The company's ability to maintain high profit margins demonstrates its strong brand and efficient operations.
*   **Low Risk Profile (MRI):**  The MRI suggests that the stock is relatively stable compared to the broader market.
*   **Potential for Mean Reversion:**  The relative divergence being at its historical low could indicate an opportunity for the stock to catch up to the market.

**Recommendation:**

Based on this analysis, a **cautious approach** is recommended. While the company has some positive attributes, the significant underperformance and negative expected return are concerning. Before making any investment decisions, investors should:

*   **Investigate the causes of the underperformance:** Understand why CL has lagged behind the S&P 500 and whether there are any plans to address this.
*   **Examine the negative expected return:**  Determine the assumptions behind this projection and assess its validity.
*   **Monitor recent news and events:** Stay informed about the company's performance and any developments that could impact its stock price.
*   **Analyze financial statements in detail:** A deeper dive into the financials can provide a clearer picture of the company's financial health and future prospects.
*   **Consider alternative investments:** Explore other investment opportunities that may offer better returns and lower risks.
